Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 4Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4

Conditions

Lymphoma 1600Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Lymphoma, Non-Hodgkin 1231Leukemia, Lymphocytic, Chronic, B-Cell 1090Lymphoma, Follicular 979Lymphoma, Large B-Cell, Diffuse 853Leukemia 790Hodgkin Disease 777Lymphoma, Mantle-Cell 675Leukemia, Myeloid, Acute 540Burkitt Lymphoma 507Lymphoma, B-Cell, Marginal Zone 490Multiple Myeloma 483Myelodysplastic Syndromes 371Lymphoma, Large-Cell, Immunoblastic 366Recurrence 363Lymphoma, T-Cell, Cutaneous 313Neoplasms 309Waldenstrom Macroglobulinemia 307Lymphoma, Large-Cell, Anaplastic 254Mycosis Fungoides 252Lymphoma, B-Cell 231Sezary Syndrome 229Blast Crisis 210Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 208Myeloproliferative Disorders 205Leukemia, Myelogenous, Chronic, BCR-ABL Positive 189Neoplasms, Plasma Cell 188Leukemia, Myeloid, Accelerated Phase 186Leukemia, Myeloid, Chronic-Phase 179

Interventions

tofacitinib 1sodium luminolate 1ixekizumab 1baricitinib 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Plaque, Amyloid × Lymphoid × Clear all
NCT01490632 2019-09-27

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Eli Lilly and Company

Phase 2 Completed
271 enrolled 32 charts
Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, Plaque, Amyloid

NCT01107457 2019-09-24

A Study in Participants With Moderate to Severe Psoriasis

Eli Lilly and Company

Phase 2 Completed
142 enrolled 45 charts
Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Plaque, Amyloid

NCT02908347 2019-01-23

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

MetrioPharm AG

Phase 2 Completed
46 enrolled 24 charts
Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Plaque, Amyloid

NCT01241591 2018-12-26

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Pfizer

Phase 3 Completed
1,101 enrolled 46 charts
Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis, Plaque, Amyloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡